Literature DB >> 11100381

The resection of non-hepatic intraabdominal recurrence of gastric cancer.

I Takeyoshi1, S Ohwada, T Ogawa, Y Kawashima, T Ohya, S Kawate, Y Nakasone, K Arai, T Ikeya, Y Morishita.   

Abstract

BACKGROUND/AIMS: Surgical resection of hepatic or pulmonary metastases from gastrointestinal cancer has been recognized as a curative modality in some patients. However, the role and outcome of the surgical management of a non-hepatic intraabdominal recurrence of gastrointestinal cancer have not been clearly delineated.
METHODOLOGY: We treated 5 patients for non-hepatic intraabdominal recurrence of gastric carcinoma surgically. All the resected specimens were microscopically identified as recurrent gastric cancer. Three of 5 patients received postoperative chemotherapy. The clinicopathological findings were analyzed according to the general rules for gastric cancer study.
RESULTS: The lymph nodes were dissected for lymph node metastases. Surgical resection of the tumors combined with total gastrectomy, esophagectomy, or colectomy was performed for the local and peritoneal recurrences. All of the recurrent tumors were macroscopically resected with curative states. One patient died of sepsis 54 days after surgery. Three patients died of recurrent gastric cancer: 2 within 1 year of surgery and 1 after 3 years. One patient still survives disease free 3 years and 6 months after the 2nd operation.
CONCLUSIONS: Surgical resection for non-hepatic intraabdominal recurrence of gastric cancer is the treatment of choice for selected patients. Surgical resection followed by adjuvant chemotherapy may improve the outcome of these patients.

Entities:  

Mesh:

Year:  2000        PMID: 11100381

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

1.  Treatment for isolated loco-regional recurrence of gastric adenocarcinoma: does surgery play a role?

Authors:  Fabio Carboni; Pasquale Lepiane; Roberto Santoro; Riccardo Lorusso; Pietro Mancini; Massimo Carlini; Eugenio Santoro
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

2.  Patterns of surveillance following curative intent therapy for gastroesophageal cancer.

Authors:  Renata D Peixoto; Howard J Lim; Haerin Kim; Ahmad Abdullah; Winson Y Cheung
Journal:  J Gastrointest Cancer       Date:  2014-09

Review 3.  Follow-up of gastric cancer: a review.

Authors:  John Whiting; Takeshi Sano; Makoto Saka; Takeo Fukagawa; Hitoshi Katai; Mitsuru Sasako
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

4.  Adrenal metastases from adenocarcinoma of the esophagogastric junction: adrenalectomy and long-term survival.

Authors:  Uberto Fumagalli; Stefano de Carli; Stefano de Pascale; Lorenza Rimassa; Mario Bignardi; Riccardo Rosati
Journal:  Updates Surg       Date:  2010-08

5.  Outcome of surgical treatment for patients with locoregional recurrence of gastric cancer.

Authors:  Souya Nunobe; Naoki Hiki; Shigekazu Ohyama; Susumu Aikou; Takeshi Sano; Toshiharu Yamaguchi
Journal:  Langenbecks Arch Surg       Date:  2010-12-14       Impact factor: 3.445

6.  Surgical treatment of recurrent gastric cancer.

Authors:  Alvaro Díaz de Liaño; Concepción Yarnoz; Rubén Aguilar; Cristina Artieda; Héctor Ortiz
Journal:  Gastric Cancer       Date:  2008-03-29       Impact factor: 7.370

7.  Surgical resection of late solitary locoregional gastric cancer recurrence in stomach bed.

Authors:  Masanori Watanabe; Hideyuki Suzuki; Kentaro Maejima; Osamu Komine; Satoshi Mizutani; Masanori Yoshino; Hideki Bo; Yasuhiko Kitayama; Eiji Uchida
Journal:  Med Sci Monit       Date:  2012-07

8.  Early gastric cancer metastasizing to the rectum, possibly via a hematogenous route: a case report and review of literature.

Authors:  Norio Uemura; Junji Kurashige; Keisuke Kosumi; Masaaki Iwatsuki; Kohei Yamashita; Shiro Iwagami; Yoshifumi Baba; Yasuo Sakamoto; Yuji Miyamoto; Naoya Yoshida; Yumi Honda; Yoshiki Mikami; Hideo Baba
Journal:  Surg Case Rep       Date:  2016-06-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.